Procept BioRobotics Corp

NASDAQ:PRCT   3:59:53 PM EDT
45.07
-1.20 (-2.59%)
Positive Earnings Pre-Announcement

Procept Biorobotics Reports Q2 Results And Increases 2022 Revenue Guidance

Published: 08/04/2022 21:04 GMT
Procept BioRobotics Corp (PRCT) - Procept Biorobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance.
Sees FY Revenue Up 91 to 97 Percent.
Sees FY Revenue $66 Million to $68 Million.
Q2 Revenue Rose 97 Percent to $16.7 Million.
Qtrly Loss per Share $0.43.
Q2 Earnings per Share View $-0.48, Revenue View $14.4 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $61.5 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $16.79 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $18.81 Million
Next Quarter EPS Guidance is expected to be -$0.51

More details on our Analysts Page.